External Beam Partial Breast Irradiation for Early Breast Cancer
##plugins.themes.bootstrap3.article.details##
Objective: In this study, our purpose was to demonstrate the feasibility and effectiveness of external beam partial breast irradiation (PBI) in patients with early-stage breast cancer treated with breast-conserving surgery.
Methods: 100 patients were treated with PBI with doses ranging from 35 to 38.5 Gy, in 10 fractions b.i.d. All patients were treated with four non-coplanar fields. The clinical tumor volume was well encompassed within the isodose line of 100 % as well as the planning target volume which was within the isodose line of 95 %.
Results: The median follow-up was of 54.3 months. The treatment was well tolerated, with no more than grade I toxicity. So far, there has been one patient with local and axillar recurrence.
Conclusions: In our experience, the treatment was well tolerated with low toxicity and with good results, in a shorter treatment time, with the economical benefits this has, especially for populations in developing countries.
cáncer temprano de mama, radioterapia externa parcial acelerada, dosis de 35 a 38, 5 Gy suministradas en una semana, Early breast cancer, external beam partial breast irradiation, doses from 35 to 38.5 Gy delivered in one week,
Greco M et al. Twenty-year follow-up
of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-32.
2. Fischer B, Anderson S, Bryant J et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-41.
3. Clark RM, Whelan T, Levine M et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst. 1996;88:1659-64.
4. Holli K, Saaristo R, Isola J et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer. 2001;84:429-38.
5. Liljergen G, Holmberg L, Bergh J et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326-33.
6. Fisher ER, Dignam J, Tan-Chiu E et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer. 1999;86:429-38.
7. King TA, Bolton JS, Kuske RR et al. Long term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for (Tis,1,2) breast cancer. Am J Surg. 2000;180:299-304.
8. Vicini FA, Remouchamps V, Wallace M et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conservative surgery. Int J Radia Oncol Biol and Phys. 2003;57:1247-53.
9. Formenti SC, Rosenstein B. Skinner KA et al. T1 stage breast cancer, adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients-pilot feasibility study. Radiology. 2002;222:171-8.
10. Orecchia R, Ciocca M, Lazzari R et al. Intraoperative radiation therapy with electrons in early stage breast cancer. Breast J. 2003;12:483-90.
11. Norris D, Thomas J. Upgrade on NSABPB39/ RTOG Clinical Trial: comparating partial to whole breast irradiation therapy. Oncology Issues [internet]. 2008 Jan-Feb:20-1. 2008. Available from: http://accc-cancer.org/oncology_issues/articles/janfeb08/norris.pdf.